A century-old discovery, valproate remains a powerful yet high-risk medical enigma today.

Nature · Published 3 October 2026 Swipe more like this →

In short: Synthesized in 1881, valproate is a cornerstone treatment for epilepsy and bipolar disorder. Yet, its precise mechanism remains unclear, and it carries significant risks, including severe birth defects and organ toxicity. Now, strict international regulations govern its use, marking a shift in how we balance efficacy against profound patient safety.

Valproate, a branched short-chain fatty acid, has been a staple in medicine since its clinical debut in 1962. Despite its inclusion on the World Health Organization's List of Essential Medicines and its status as a common prescription, scientists still do not fully understand how it works. Current theories suggest it may modulate GABA levels, block voltage-gated sodium channels, or influence gene expression by inhibiting histone deacetylases.

The drug's utility is broad, spanning the management of tonic–clonic, absence, and myoclonic seizures, as well as manic episodes in bipolar disorder. However, this versatility comes with a steep price. Valproate is a known teratogen, carrying an 11% risk of birth defects and a 30–40% risk of permanent neurodevelopmental disabilities in exposed fetuses. Consequently, the United States Food and Drug Administration has issued black box warnings regarding fetal abnormalities, alongside risks for hepatotoxicity and pancreatitis.

These dangers have prompted increasingly stringent global oversight. In the United Kingdom and the European Union, the drug is now restricted for both men and women under age 55 due to concerns regarding teratogenicity and male fertility. In the United States, clinicians must navigate these same severe side effects, which also include potential weight gain, reduced platelet counts, and growth plate issues in children. Because valproate interacts with numerous other medications—from aspirin to antibiotics—and can lead to fatal outcomes in overdose, its administration requires rigorous monitoring.

Beyond its primary uses, researchers have explored valproate for conditions ranging from migraine prophylaxis to potential applications in cancer and AIDS treatment. Yet, the clinical reality remains cautious. Whether managing epilepsy or psychiatric symptoms, the drug serves as a stark reminder of the complexity inherent in pharmacology, where a single molecule can offer life-changing relief while simultaneously posing systemic risks that demand constant, careful vigilance.

General information, not professional advice. Spotted an error? Flag the card or see corrections and complaints.

Intellect Plus is a visual educational discovery platform for exploring fascinating facts and ideas. Brain Food, Not Brain Rot. What is Intellect Plus?

Related

• In 1978 Americans got through more than 2 billion Valium tablets
• How a 1953 discovery became a cornerstone for treating epilepsy and nerve pain
• Benzodiazepines were the world’s top prescriptions by 1977
• The accidental discovery that changed how we treat anxiety and alcohol withdrawal forever
• Phenobarbital is a powerful sedative that has been used to control seizures since 1912.
• A twelve-year-old on Réunion cracked the secret that made vanilla global
• The USS Wasp was a flawed carrier built to exploit a treaty loophole.
• The world's smallest porpoise is fighting extinction in a tiny corner of Mexico
• The polar bear is a master of the Arctic, but its future is melting away
• Why a 1980s farming decision triggered a rare and fatal human brain epidemic
• Why these arachnids spray vinegar and carry their young on their backs
• The parasitic mite that threatens honey bee colonies worldwide with rapid, lethal population growth.

More in Organisms · More in Nature · Latest · A–Z · All topics